• Home
  • About Us
  • Contact
  • Subscribe
  • Your Account
  • Login
No Result
View All Result
Friday, June 2, 2023
Alternatives Watch
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
No Result
View All Result
Alternatives Watch
No Result
View All Result

Healthcare hedge funds stage dramatic double-digit comeback in 2019

Susan BarretobySusan Barreto
January 12, 2020
in Hedge Funds, Manager News, Open Access
Healthcare hedge funds stage dramatic double-digit comeback in 2019
ShareTweetShareSendSend

Often maligned biotech/life sciences hedge funds logged exceptional double digit returns in the last 12 months as other long/short equity managers struggled to even come close to the S&P 500’s 30% plus gains.

The rise of biopharma initiatives aimed at rare diseases, new medical devices and an aging baby boomer population are the backdrop for what observers expect to be another blockbuster year in the space.

For example, Perceptive Advisors reported year-to-date returns of roughly 52% through December 27 for its Perceptive Life Sciences Offshore Fund, which would put 2019 as a dramatic comeback year after 2018’s year-end losses of 8.34%.

The HFRI Equity Hedge Healthcare index finished 2019 up 23.41% and helping equity hedge fund managers ranking as the top performing hedge fund strategy for the year with gains of 13.9%, which were the strongest since 2013, according to recently published numbers from HFR.

2019 was a year where hedge funds posted their highest annual performance since the financial crisis recovery, according to Kenneth Heinz, presiding of HFR.

“Global financial markets experienced a correlated melt up in 2019, with strong gains across equities (led by US Technology), fixed income, commodities and currencies,” said Heinz in a press statement.

Still the healthcare gains shone brightly after a tough 2018, with HFR’s Equity Hedge Healthcare index having returned 1.85% after gains of more than 18% in 2017.

Volatility is ever present in the biotech space, however, and is often viewed as a detractor to the strategy by investors. Yet, 2019 was a year that saw healthcare strategies on top much of the time.

RTW Investments manages nearly $2 billion in the sector and is one of the top shareholders of Rocket Pharmaceuticals, a multi-platform clinical-stage gene therapy company that focuses on rare diseases. Following a reverse merger with pharmaceutical firm Inotek, Rocket began trading on the Nasdaq in early 2018.

This year, RTW expects to report some strong 2019 gains. In the first half of 2019, the firm’s flagship fund was up over 22%. Driving gains were companies with breakthrough therapies in areas like oncology and genetic diseases.

According to RTW founder and CIO Rod Wong, there are a relatively small number of leading specialist firms that focus on just private, just public or both public and private healthcare investments. RTW is active on both the public and private side of biotech, which is not unusual for alternative investment firms as large mandates are also swirling in the area of private credit with a life sciences focus.

“Outside of the specialists our sense is actually that generalist firms/investors have been very slow to come back to the space since a mass exodus last happened in 2015,” says Wong.

Tags: Long/short
ShareTweetShareSendSend
Previous Post

Nuveen launches $21bn private capital platform

Next Post

Connecticut adds $425m to private markets

Related Posts

Activist investor Jana Partners escalates Freshpet battle with court filing
Hedge Funds

Activist investor Jana Partners escalates Freshpet battle with court filing

Rockhampton shuts pan-Asia fund
Hedge Funds

Rockhampton shuts pan-Asia fund

Millennium hires ex-Balyasny analyst Starikovsky as senior PM
Hedge Funds

Millennium hires ex-Balyasny analyst Starikovsky as senior PM

Evanston Capital: Concentrated bets to tame complex markets
Hedge Funds

Evanston Capital: Concentrated bets to tame complex markets

Trend-following 'first mover' Quest Partners embraces volatility surge
CTAs/Managed Futures

Trend-following ‘first mover’ Quest Partners embraces volatility surge

Next Post
Connecticut adds $425m to private markets

Connecticut adds $425m to private markets

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Activist investor Jana Partners escalates Freshpet battle with court filing

Activist investor Jana Partners escalates Freshpet battle with court filing

Rockhampton shuts pan-Asia fund

Rockhampton shuts pan-Asia fund

Millennium hires ex-Balyasny analyst Starikovsky as senior PM

Millennium hires ex-Balyasny analyst Starikovsky as senior PM

AW Top 10 reads for May 2023

AW Top 10 reads for May

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Investor News
  • Private Equity
  • Private Credit
  • Hedge Funds
  • Real Estate/Infrastructure
  • Subscribe
  • Your Membership
  • Terms of Service
  • Privacy Policy

Follow Us

No Result
View All Result
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

This Website Uses Cookies
We use cookies on our website to provide necessary functions. By clicking “Accept”, you consent to the use of all strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo